Condition
Refractory Ventricular Tachycardia
Total Trials
5
Recruiting
2
Active
2
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 25/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (5)
Trial Status
Unknown2
Recruiting2
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT05337241Not ApplicableRecruitingPrimary
Saline Enhanced Radiofrequency (SERF) Needle Ablation for Refractory VT
NCT06294782Not ApplicableRecruitingPrimary
PrOsPective Cohort Study for STereotactic Arhythmia Radioablation (STAR) of Refractory Ventricular Tachycardia
NCT04066517Not ApplicableUnknownPrimary
STereotactic RadioAblation by Multimodal Imaging for VT (STRA-MI-VT)
NCT03349892Not ApplicableCompletedPrimary
Stereotactic Ablative Radiotherapy for Refractory Ventricular Tachycardia
NCT02646501Not ApplicableUnknownPrimary
Prospective Randomized Clinical Trial for Effect of Stellate Ganglion Block in Medically Refractory Ventricular Tachycardia
Showing all 5 trials